Numerical Simulation of Oncolytic M1 Cancer Virotherapy Reaction-Diffusion Model by Collocation of B-Splines
Main Article Content
Abstract
Cancer is a leading cause of death worldwide. Invention of better cancer treatment strategies remained a burning topic of the research since decades. Oncolytic virotherapy being a targeted type therapy is an emerging technology that uses selective engineered viruses to treat cancerous malignancies. The dynamics of oncolytic M1 virotherapy with spatial effects and anti-tumour immune responses cab better be studied and analysed with reaction-diffusion mathematical models. A
reaction-diffusion mathematical model to characterize the dynamics of oncolytic M1 alphavirus in the cancer treatment virotherapy with immune responses is studied in this paper. A numerical simulation technique based on the collocation of cubic B-splines is proposed to approximate the solution of the considered reaction-diffusion model. Collocation forms of the partial differential equation results in a system of first order ordinary differential equations which in turn have been solved by Runge-Kutta method of order 4. The non-linearity of the model is being resolved without any transformation or
linearization. The computed numerical results are in good agreement with those expected. Easy to apply and achieving accurate solutions in less CPU time are the key points of the present approach.
Downloads
Metrics
Article Details
Licensing
TURCOMAT publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
